ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07609
-0,11%
Bitcoin
64.057,00
0,26%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Amarantus Bioscience Holdings Inc (CE) (AMBS)

  7. Amarantus Bioscience Holdings Inc (CE) (AMBS) News

AMBS

Amarantus Bioscience (CE) (AMBS)

Amarantus Bioscience Holdings Inc (CE)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:AMBS
DatumZeitQuelleÜberschriftSymbolFirma
09/09/202220h20Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)USOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
18/04/202222h18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
18/04/202222h14Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
09/10/202012h02Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
05/10/202023h25Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
05/10/202023h22Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
10/07/202021h03InvestorsHub NewsWireTodos Medical Expands Extraction Reagent and ANDiS 350 Extraction Automation Capacity to Support COVID-19 Testing in the USAUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
30/01/202015h42InvestorsHub NewsWireAmarantus Acquires Majority Interest in CBD Wellness Company HemporiUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
10/01/202012h52Edgar (US Regulatory)Withdrawal of Offering Statement Under Regulation a (1-a-w)USOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
09/01/202023h13Edgar (US Regulatory)Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)USOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
09/01/202023h06Edgar (US Regulatory)Registration a Offering Under the Securities Act of 1933 (1-a)USOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
04/12/201914h17InvestorsHub NewsWireAmarantus Sub Elto Pharma Gets Notice of Allowance Covering Use of Eltoprazine Combined with CBD to Treat Parkinson's DiseaseUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
24/10/201915h52InvestorsHub NewsWireAmarantus Enters Into Agreement to License Diverse Therapeutics Portfolio to CBD-focused Emerald Organic ProductsUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
27/09/201921h49Edgar (US Regulatory)Registration a Offering Under the Securities Act of 1933 (1-a)USOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
28/05/201915h51InvestorsHub NewsWireAmarantus Engages Evolution Venture Partners to Evaluate Strategic Alternatives for Expansion into the Legal Hemp IndustryUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
07/01/201914h00InvestorsHub NewsWireAmarantus Provides 2019 RoadmapUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
28/11/201813h30InvestorsHub NewsWireCoeptis Pharma Enters into Agreement to Acquire Elto PharmaUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
20/07/201813h31InvestorsHub NewsWireAmarantus Provides Corporate UpdateUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
09/07/201814h00InvestorsHub NewsWireMANF Therapeutics Announces Positive MANF Pre-Clinical Data in Alpha-Synuclein Model of Parkinson's Disease Published inUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
11/06/201813h00InvestorsHub NewsWireMANF Therapeutics Announces Independent Publication of Positive Data for MANF in Traumatic Brain Injury Animal ModelUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
07/06/201814h17InvestorsHub NewsWireAmarantus Provides Update on Elto Pharma Capital Formation PlanUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
05/06/201814h11InvestorsHub NewsWireMANF Therapeutics Announces Publication of Positive Data for MANF in Stroke Animal Model in AAAS Journal Science AdvancesUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
30/05/201814h00InvestorsHub NewsWireAmarantus Exercises Exclusive Option with Leipzig University for Alzheimer's Blood Diagnostic "LymPro Test 2.0"USOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
24/05/201817h00InvestorsHub NewsWireAmarantus to Present at LD Micro and The Reg A ConferenceUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
22/05/201812h00InvestorsHub NewsWireAmarantus Retains Weild & Co. to Advise on JOBS Act FundingUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
21/05/201813h58InvestorsHub NewsWireMANF Therapeutics Announces Publication in Society for Neuroscience eNeuro Journal of Human Ocular Distribution and Animal..USOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
11/05/201813h00InvestorsHub NewsWireAmarantus Provides Business OverviewUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
04/05/201814h16InvestorsHub NewsWireAmarantus Enters into Exclusive Option Agreement with Leipzig University to License IP Covering Alzheimer's Blood DiagnosticUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
03/05/201815h15InvestorsHub NewsWireMANF Therapeutics Announces Issuance of Patent in Hong Kong Covering Use of MANF for Treatment of Diabetes and Wolfram's NewUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
01/05/201816h30InvestorsHub NewsWireElto Pharma Receives Notice of Allowance in Canada for Patent Covering Use of Eltoprazine to Treat non-ADHD Cognitive Impairm...USOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
 Showing the most relevant articles for your search:USOTC:AMBS

Kürzlich von Ihnen besucht

DBI
DAX
DAX
NYSE
MCD
McDonalds
AMEX
XLV
Health Care Select Sector
TG
NOV
Novo Nordisk
FX
EURUSD
Euro vs US Dollar
NYSE
NKE
Nike
DBI
MDAX
MDAX
AMEX
SPY
SPDR S&P 500
PM
XAUUSD
Gold vs US Dollar
NYSE
KO
Coca Cola
TG
DTE
Deutsche Telekom
DBI
SDXP
SDAX
NASDAQ
MSFT
Microsoft
TG
DBK
Deutsche Bank
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten